Ascendis Pharma A/SNASDAQ:ASND
- LAST PRICE145.7200
- TODAY'S CHANGE (%)1.1000 (0.7606%)
- Bid / Lots145.3200/ 1
- Ask / Lots145.8000/ 1
- Open / Previous Close143.6900 / 144.6200
- Day Range
- 52 Week Range
- Volume246,314
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ASND |
|---|---|---|
| 09:32 ET | 942 | 144.55 |
| 09:39 ET | 12456 | 145.54 |
| 09:41 ET | 200 | 144.79 |
| 09:43 ET | 100 | 145.32 |
| 09:48 ET | 500 | 144.78 |
| 09:50 ET | 300 | 145.31 |
| 09:54 ET | 100 | 145.535 |
| 09:57 ET | 4180 | 145.33 |
| 10:01 ET | 1280 | 144.67 |
| 10:03 ET | 4425 | 145.09 |
| 10:06 ET | 15000 | 144.665 |
| 10:08 ET | 1100 | 145.46 |
| 10:10 ET | 5500 | 145.37 |
| 10:12 ET | 11100 | 144.63 |
| 10:14 ET | 3062 | 145.47 |
| 10:15 ET | 400 | 145.47 |
| 10:17 ET | 1000 | 145.2 |
| 10:19 ET | 200 | 144.61 |
| 10:21 ET | 920 | 144.76 |
| 10:24 ET | 200 | 144.76 |
| 10:26 ET | 400 | 144.76 |
| 10:30 ET | 43253 | 144.665 |
| 10:32 ET | 900 | 145.49 |
| 10:33 ET | 300 | 145.5975 |
| 10:35 ET | 400 | 145.475 |
| 10:39 ET | 500 | 145.48 |
| 10:42 ET | 400 | 145.33 |
| 10:44 ET | 4130 | 145.32 |
| 10:48 ET | 20468 | 145.295 |
| 10:50 ET | 201 | 145.04 |
| 10:51 ET | 8563 | 145.35 |
| 10:53 ET | 700 | 144.99 |
| 10:57 ET | 400 | 144.84 |
| 11:00 ET | 400 | 145.14 |
| 11:02 ET | 500 | 144.84 |
| 11:04 ET | 8568 | 145.38 |
| 11:06 ET | 700 | 144.87 |
| 11:08 ET | 3008 | 144.97 |
| 11:09 ET | 100 | 144.97 |
| 11:11 ET | 1220 | 145.02 |
| 11:13 ET | 725 | 145.09 |
| 11:15 ET | 300 | 145.34 |
| 11:18 ET | 2120 | 145.04 |
| 11:22 ET | 100 | 144.76 |
| 11:26 ET | 7210 | 144.715 |
| 11:27 ET | 2775 | 145.09 |
| 11:29 ET | 9448 | 144.775 |
| 11:31 ET | 300 | 144.89 |
| 11:33 ET | 200 | 144.94 |
| 11:36 ET | 3691 | 144.67 |
| 11:38 ET | 3699 | 144.725 |
| 11:40 ET | 2390 | 144.6 |
| 11:45 ET | 100 | 144.81 |
| 11:47 ET | 100 | 144.81 |
| 11:49 ET | 100 | 144.81 |
| 11:51 ET | 100 | 144.99 |
| 11:54 ET | 1520 | 144.96 |
| 12:00 ET | 200 | 145.2 |
| 12:03 ET | 600 | 145.3 |
| 12:07 ET | 100 | 145.53 |
| 12:09 ET | 2834 | 145.13 |
| 12:14 ET | 6505 | 144.91 |
| 12:16 ET | 1650 | 144.82 |
| 12:18 ET | 100 | 145.145 |
| 12:20 ET | 100 | 145.325 |
| 12:21 ET | 1000 | 145.09 |
| 12:23 ET | 100 | 145.225 |
| 12:27 ET | 100 | 145.24 |
| 12:30 ET | 384 | 146.052 |
| 12:32 ET | 100 | 145.96 |
| 12:34 ET | 100 | 146.28 |
| 12:36 ET | 11054 | 145.38 |
| 12:38 ET | 1256 | 146.155 |
| 12:39 ET | 102 | 145.78 |
| 12:41 ET | 450 | 145.62 |
| 12:43 ET | 100 | 145.865 |
| 12:45 ET | 100 | 145.82 |
| 12:48 ET | 100 | 145.81 |
| 12:50 ET | 100 | 145.56 |
Today
New 3-Year Skeletal Dynamics Data for Adults with Hypoparathyroidism Treated with TransCon(TM) PTH (Palopegteriparatide) Presented at ASBMR 2024, from 4 hours ago by Dow Jones
4 hours ago by Dow JonesAscendis Pharma Announces Submission of Supplemental Biologics License Application to FDA for TransCon(TM) hGH for the Treatment of Adults with Growth Hormone Deficiency, from 4 hours ago by Dow Jones
4 hours ago by Dow Jones
Sep 23, 2024
DJ Ascendis Pharma Is Maintained at Buy by B of A Securities, from 12:14PM ET on Monday Sep 23, 2024 by Dow Jones
12:14PM ET on Monday Sep 23, 2024 by Dow Jones
Sep 19, 2024
*DJ Ascendis Pharma Prices Underwritten Public Offering of 2M ADSs at $150.00 Each >ASND, from 9:58PM ET on Thursday Sep 19, 2024 by Dow Jones
9:58PM ET on Thursday Sep 19, 2024 by Dow JonesAscendis Pharma A/S Announces Pricing of Public Offering of ADSs, from 8:16PM ET on Thursday Sep 19, 2024 by Dow Jones
8:16PM ET on Thursday Sep 19, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ascendis Pharma A/S | 6.9B | -15.1x | --- |
Intra-Cellular Therapies Inc | 8.0B | -84.8x | --- |
Tempus AI Inc | 7.6B | -6.7x | --- |
Legend Biotech Corp | 9.2B | -31.0x | --- |
Viking Therapeutics Inc | 7.4B | -67.2x | --- |
Revolution Medicines Inc | 7.3B | -12.4x | --- |
Company Information
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
Contact Information
- Headquarters
- Tuborg Boulevard 12HELLERUP, Denmark 2900
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Albert Cha
- President, Chief Executive Officer, Executive Director, Member of the Executive Board
- Jan Moller Mikkelsen
- Chief Financial Officer, Executive Vice President, Member of the Executive Board
- Scott Smith
- Executive Vice President, Chief Administrative Officer
- Lotte Soenderbjerg
- Executive Vice President, Global Chief Commercial Officer
- Camilla Hartvig
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.9B |
|---|---|
Revenue (TTM) | $354.6M |
Shares Outstanding | 58.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.63 |
EPS | $-9.63 |
Book Value | $-2.82 |
P/E Ratio | -15.1x |
Price/Sales (TTM) | 19.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -111.27% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
